LDL-IN-3

CAS No. 180908-67-2

LDL-IN-3( —— )

Catalog No. M32741 CAS No. 180908-67-2

LDL-IN-3 shows anti-atherosclerotic and antioxidant activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 849 In Stock
5MG 735 In Stock
10MG 938 In Stock
25MG 1473 In Stock
50MG 1841 In Stock
100MG 2613 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LDL-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    LDL-IN-3 shows anti-atherosclerotic and antioxidant activities.
  • Description
    LDL-IN-3 is an anti-atherosclerotic compound extracted from patent WO/2005/039596A1, example C25 and patent US 6133467, example 3.
  • In Vitro
    LDL-IN-3 is antioxidant which inhibits low density lipoprotein (LDL) lipid peroxidation and is useful as anti-atherosclerotic agents.
  • In Vivo
    LDL-IN-3 decreases serum cholesterol, TBARS and the amount of aortic lesions (57 %) in comparison with control rabbits. LDL-IN-3 is found in very high concentrations in the serum (182.4 μg/mL) and livers (323 μg/mL).
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Antioxidant
  • Recptor
    Antioxidant
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    180908-67-2
  • Formula Weight
    400.63
  • Molecular Formula
    C24H36O3Si
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C[Si](C)(C)C1=CC=C(OC)C=C1)C2=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. WO/2005/039596A1
molnova catalog
related products
  • Valepotriate

    Valepotriate fraction can have sedative effects and affect behavioral parameters related to recognition memory.

  • MnTBAP chloride

    MnTBAP chloride (Mn(III)TBAP) is a cell-permeable superoxide dismutase (SOD) mimetic and peroxynitrite scavenger that reduces the doubling time of SOD-E. coli by a factor of 2.

  • Atractylenolide II

    Atractylenolide II has antimelanoma effect by inhibiting STAT3 signalling. Atractylenolide II has cytotoxic/apoptotic effects may via p38 activation , ERK and Akt inactivation, p53 dependent.